You've built the science.
We'll help build the business.

Fractional Leadership and Management Consulting for the Life Sciences
Go-To-Market • Market Intelligence • Capital Advisory • Regulatory Affairs

Great Science Needs Great Commercial Strategy.

Our purpose-built AI platforms and seasoned life science operators make sure your commercial strategy holds up when it matters most: raising capital, launching products, and positioning for exits. We help you build commercial strategy on evidence, not opinions.

Our Vision

Our Vision

Advancing human health by strengthening the business behind life science innovation.

Great science deserves great commercialization. We exist to make sure breakthroughs reach the patients, markets, and outcomes they were built for.

How We Help

How We Help

Management consulting and fractional leadership that turns innovation into sustainable growth.

We align strategy, systems, process, and execution, and solve the problems that derail life science companies: failed launches, underperforming revenue, and raises that stall because investors spot the gaps before you do.

Why We're Unique

Why We're Unique

Objective, evidence-based analysis you can trust, not subjective opinions and a slide deck.

Traditional consulting is expensive, slow, and subjective. Generic AI lacks the consistency serious commercial decisions require. We solved both. Our platforms pinpoint critical go-to-market gaps, and our seasoned operators fix them.

Who We Serve

Who We Serve

Leaders at early- and growth-stage life science and diagnostic companies, and their investors.

CEOs, founders, and commercial leaders navigating product launches, market access, and scaling operations, plus investors and board members who need a structured, evidence-based commercial readiness assessment to inform funding decisions.

Proven Results

A few of the outcomes behind the work.

$8M Bridge We cut an early-stage life sciences platform company from ten markets to three. It helped secure the raise and now anchors their strategy. Learn more → $10M in Year One A stalled launch, slipped eighteen months, shipped in two after we built and drove the plan. Learn more → New Platform Product Requirements A competitive teardown, narrowed to the three closest competitors, helped drive the product requirements for a next-gen platform. Learn more → Years & Millions Saved We steered an international launch away from a costly solo market-access build toward a partner path. Learn more → Failing Strategy, Caught in Real Time An early-stage life sciences company's strategy was headed for failure across key markets. Our read of the global clinical landscape caught it and refocused it on where it could win. Learn more → Sharper Customer Fit A biomanufacturing software company with strong proof was aimed at the wrong buyer. We defined the ideal customer and screened out low-fit prospects earlier. Learn more → Sales, Made Repeatable A genomics services team closed simple deals but missed complex ones. We built the 360 diagnosis, territory and account planning, and a prioritized enablement roadmap. Learn more →

Let's Build What's Next. Together.

Proven Commercial Experience

Danaher Illumina Roche Thermo Fisher Scientific BD Element Biosciences Pictor Metabolon Danaher Illumina Roche Thermo Fisher Scientific BD Element Biosciences Pictor Metabolon Danaher Illumina Roche Thermo Fisher Scientific BD Element Biosciences Pictor Metabolon